Navigation Links
Derma Sciences to Present at The Rodman & Renshaw 10th Annual Healthcare Conference
Date:10/29/2008

PRINCETON, N.J., Oct. 29 /PRNewswire-FirstCall/ -- Derma Sciences, Inc. (OTC Bulletin Board: DSCI), a company specializing in advanced wound care products, announced it will present at the upcoming Rodman & Renshaw Annual Global Investment Conference taking place at the New York Palace Hotel in New York City. The Company is scheduled to present on November 12 at 10:45 am in the Adams room located on the 4th floor.

Management will discuss the Company's business strategy and their latest advanced wound care products. A live webcast of the presentation can be viewed at:

http://www.wsw.com/webcast/rrshq14/dsci.ob/

The webcast will automatically be archived approximately three hours after the live event and will be available for 90 days through February 12, 2009.

More information on the Rodman & Renshaw 10th Annual Healthcare Conference can be found at: http://www.rodm.com/conferences?id=19

About Derma Sciences

Derma Sciences is a global manufacturer and marketer of advanced wound-care products. Its key product, MEDIHONEY(TM), is sold throughout the world by Derma Sciences and Comvita New Zealand -- the licensor of the patented honey-based technology -- and is the leading brand of honey-based dressings for the management of wounds and burns. The product has been shown to be effective in a variety of wounds and burns, and was recently the focus of a large-scale randomized controlled trial on leg ulcers. Derma has two products in development: the BIOGUARD(TM) line of barrier gauze dressings, and DSC127, the company's novel angiotensin analog for accelerated wound healing and scar reduction. The barrier technology was licensed from Quick-Med in Q1 of 2007 and is pending its initial FDA marketing clearance. DSC127 was licensed from The University of Southern California in Q4 of 2007 and is entering into a Phase II study, with anticipated initial patient enrollment to begin in Q3 of 2008. For more information about Derma Sciences, Inc., visit its home page on the Internet at http://www.dermasciences.com.

Contact: Derma Sciences, Inc. Allen & Caron Inc

Edward J. Quilty Rudy Barrio (US Investors)

Chairman and CEO r.barrio@allencaron.com

equilty@dermasciences.com

(609) 514-4744 Brian Kennedy (media)

brian@allencaron.com

(212) 691-8087


'/>"/>
SOURCE Derma Sciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Derma Sciences Announces 3-Year Licensing Deals for Highly Profitable Character Strip Bandages
2. Derma Sciences Announces Commercial Launch of XTRASORB(TM)
3. Avidas Pharmaceuticals Signs Agreement to Acquire North American Rights to Products That Address Chronic Dermatologic Conditions
4. Age Spots Are No Match for Cosmetic Dermatology Treatments
5. Dermatologists Score Healthy First for Fans at Final Tennis Tournament Before U.S. Open
6. Watson Announces Limited Recall of Fentanyl Transdermal System
7. Derma Sciences Conference Call Advisory
8. American Academy of Dermatology: Dermatologists Warn Ceramic Flat Irons Could Damage Hair and Lead to Hair Breakage
9. American Academy of Dermatology: Acne and Rosacea Got You Seeing Red? Patients with Skin of Color Advised to Seek Proper Diagnosis, Treatment to Prevent Common Side Effects
10. Galderma announces approval for Differin gel 0.1 percent in Japan
11. Dermatologists In Denial: Controversial New Chocolate Nutraceutical Claims to be Good for Your Skin
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... ... February 22, 2017 , ... The ... today, as organizations, advocates, and individuals join together to increase recognition about the ... ultimately save lives. , “Today we mark a nationwide movement to raise awareness ...
(Date:2/22/2017)... ... February 22, 2017 , ... A product of digesting a ... derive a heart-protective benefit from eating soy foods, while others do not, a University ... are able to produce equol—a substance made by some types of “good” gut bacteria ...
(Date:2/22/2017)... (PRWEB) , ... February 22, 2017 , ... Pet obesity ... and 54% of dogs, according to the Association for Pet Obesity Prevention (APOP). During ... key pet food issues such as the benefits of corn and grains, value of ...
(Date:2/22/2017)... ... 22, 2017 , ... In a recent article ... context (age, illness and life choices) should be dissociated from medical errors and ... In addition, all too often, studies regarding health system performance in other countries, ...
(Date:2/21/2017)... , ... February 21, 2017 , ... ... Nation Regional Medical Clinic in Durant, Oklahoma, on Feb. 21. , The celebration ... tours for community members, clinic employees, the construction team and tribal leadership. ...
Breaking Medicine News(10 mins):
(Date:2/22/2017)... , Feb 22, 2017 Research and ... Market Analysis & Trends - Industry Forecast to 2025" report to ... The Global ... around 5.2% over the next decade to reach approximately $2.1 billion by ... and forecasts for all the given segments on global as well as ...
(Date:2/22/2017)... Calif. , Feb. 22, 2017  Applied Silver, the ... Barnes to the company,s advisory board. Ms. Barnes is ... joining business, advertising, engineering, legal, and healthcare experts Scott ... John Goodrich , J. Tress Ritter , and ... BSN, CIC, FAPIC brings more than three decades of nationally ...
(Date:2/22/2017)... 2017 Oncternal Therapeutics, Inc., a clinical-stage ... and common malignancies, today announced the closing of ... intends to use the proceeds to further clinical ... advance preclinical development of a new ROR1-targeted antibody-drug ... first-in-class anti-ROR1 monoclonal antibody being developed to treat ...
Breaking Medicine Technology: